GU Cast | Urology Podcast

Giant bladder cancer paper in NEJM this week with the highly anticipated results of the perioperative EV-Pembro trial (EV-303 / KN-905). Already we can say this is a landmark publicaion in bladder cancer that will change practice and even challenge the role of cystectomy (maybe)! Declan Murphy and Renu Eapen caught up with first author Christof Vulsteke (Integrated Cancer Centre, Ghent, BEL) when we were at ESMO Asia recently and had a chat about this work and how it will change practic...

In case you missed it, or you've already abandoned Twitter (memo to self - must do that ourselves!), we witnessed some pretty toxic stuff over there in the past couple of weeks. Vile personal attacks, calls for resignations, accusations of nefarious behaviour etc etc, mostly triggered by an AI-generated infographic attempting to illustarte a recent paper in European Urology Oncology. We chat with first author Dr Riccardo Bertolo (University of Verona, ITA), about his first-hand experien...

Another of our special Themed Podcasts focussed on prostate cancer in China, supported by our Gold Partner, Bayer. We are joined as ever by our China Editor, Dr Yao Zhu (Fudan University Shanghai Cancer Centre), and also special guest Dr Yige Bao (SCU Xiamen Hospital). Not only do we learn about pandas in West China, but also some great highlights from the recent ESMO Annual Meeting in Berlin! Hosted as ever by Dr Renu Eapen and Prof Declan Murphy Even better on our YouTube channel

An exclusive behind-the-scenes look at the world-famous ORSI Academy in Belgium! Declan and Renu travelled to this remarkable facility just outside Ghent in Belgium, jammed full of tens of millions of dollars worth of robotic surgery technology from the world's top providers - Intuitive Surgical, Medtronic, Microport and more. Every day, surgeons from all around the world are getting hands-on experience using the latest robotic surgery technology in an array of training environments. Plus ORS...

We recently hosted another live webinar for our Gold Partners, Mundipharma, this time asking the question, "Is high-risk BCR actually metastatic prostate cancer??". It's a reasonable question! This podcast was anchored from the GU Cast studio in Melbourne by usual hosts, Renu Eapen and Declan Murphy, joined in person by Andrew Loblaw, radiation oncologist from Toronto, and online by medical oncologist Jeff Goh in Brisbane. Best enjoyed on our YouTube channel if you want to check out the...

Fun today as we go to the OR to test drive some high-fidelity radical prostatectomy models and chat with the team behind UroTrainer - world leaders in urologic simulation. Urologists Gonzalo Vitagliano and Maxi Ringa join us from Buenos Aries to tell us all about UroTrainer and why they have worked hard to create these beautiful models for trainees to improve their skills in minimally-invasive prostate and kidney surgery. They also tell us about their range of hands-on courses around t...

Episode 3 of our monthly GU Cast Journal Club and today we focus on one classic paper in Urology, and one from recent times - the ERSPC randomised trial of screening in prostate cancer, and the NIAGARA trial evaluating peri-operative immunotherapy in muscle-invasive bladder cancer. We are delighted to welcome back our GU Cast Journal Club Editors, Dr Carlos Delgado (Melbourne, AUS), and Dr Elena Berg (Munich, GER), along with main GU Cast Hosts, Renu Eapen and Declan Murphy. Watch out ...

Hot off the press in the Presidential Plenary at #ESMO25, we chat with Dr Scott Tagawa (Weill-Cornell, USA) about the positive data he just presented from the PSMAddition trial. This is an eagerly awaited phase III randmosied trial of patients with mHSPC, to see if the addition of six cycles of Lu-PSMA-617 to a control arm of ADT and an ARPI, could improve rPFS and other endpoints. We are also joined in the studio by Prof Michael Hofman (Peter MacCallum Cancer Centre, AUS), co-PI of the UpFro...